Skip to main content
. 2005;7(Suppl 5):S3–S12.

Figure 3.

Figure 3

The hazard ratio for survival relative to orchiectomy at 2 years based on a meta-analysis of randomized studies comparing androgen suppression monotherapies in men with advanced prostate cancer. DES, diethylstilbestrol; LHRHa, luteinizing hormone-releasing hormone agonist; NSAAs, nonsteroidal antiandrogens; studs, number of studies; pts, pooled number of patients. Reproduced with permission from Seidenfeld J et al.16